BIO ESSENCE CORP. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
BIO ESSENCE CORP. (BIOE) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $675 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- BIO ESSENCE CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was $36.18K.
- BIO ESSENCE CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$1.37K, a 6060.87% decline year-over-year.
- BIO ESSENCE CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $23.00.
- BIO ESSENCE CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$6.13K.
- BIO ESSENCE CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$1.37K, a 209.07% decline from fiscal 2024.
- BIO ESSENCE CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $1.26K.
- BIO ESSENCE CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$6.15K, a 203.17% decline from fiscal 2022.
- BIO ESSENCE CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $5.96K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $675.00 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $36.18K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | -$1.37K 10-K · filed 2026-03-27 | |||
| 2025-09-30 | $27.37K 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | -$1.37K 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | -$1.37K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $1.26K 10-K · filed 2026-03-27 | |||
| 2024-09-30 | $29.82K 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | $9.49K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $23.00 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$6.15K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | -$6.17K 10-Q · filed 2024-11-14 | |||
| 2023-03-31 | -$6.13K 10-Q · filed 2024-05-17 | |||
| 2022-12-31 | $5.96K 10-K · filed 2024-04-15 | |||
| 2022-09-30 | $269.00 10-Q · filed 2023-11-13 | |||
| 2021-12-31 | -$5.02K 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $21.39K 10-Q · filed 2021-11-12 | |||
| 2020-12-31 | -$10.84K 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $485.00 10-Q · filed 2021-11-12 |